173
Views
5
CrossRef citations to date
0
Altmetric
Case Series

Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series

ORCID Icon, , , , ORCID Icon, , , & ORCID Icon show all
Pages 149-161 | Published online: 22 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hitasha Rupani, Wei Chern Gavin Fong, Aref Kyyaly & Ramesh J Kurukulaaratchy. (2021) Recent Insights into the Management of Inflammation in Asthma. Journal of Inflammation Research 14, pages 4371-4397.
Read now

Articles from other publishers (4)

Francesco Menzella, Andrea Ballarin, Maria Sartor, Ariel Fabian Floriani, Lorenzo Corsi, Cristina Dartora, Silvia Tonin & Micaela Romagnoli. (2022) Comparison between clinical trials and real-world evidence studies on biologics for severe asthma. Journal of International Medical Research 50:11, pages 030006052211336.
Crossref
Francesco Menzella, Elena Bargagli, Maria Aliani, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Cristiano Caruso, Stefano Centanni, Maria D’Amato, Stefano Del Giacco, Fausto De Michele, Fabiano Di Marco, Elide Anna Pastorello, Girolamo Pelaia, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Gianenrico Senna, Alessandra Vultaggio, Lucia Simoni, Alessandra Ori, Silvia Boarino, Gianfranco Vitiello, Elena Altieri & Giorgio Walter Canonica. (2022) ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study. Respiratory Research 23:1.
Crossref
L. Klimek, J. Hagemann, H. J. Welkoborsky, M. Cuevas, I. Casper, U. Förster-Rurmann, F. Klimek, C. A. Hintschich, T. Huppertz, K.-Ch. Bergmann, P. V. Tomazic, C. Bergmann & S. Becker. (2021) T2-Inflammation bei entzündlichen Atemwegserkrankungen: Grundlage neuer Behandlungsoptionen. Laryngo-Rhino-Otologie 101:02, pages 96-108.
Crossref
Ludger Klimek, Karl-Christian Bergmann, Jan Hagemann, Christoph Bergmann, Ulrike Förster-Ruhrmann & Sven Becker. (2021) Typ-2-Inflammation: Stellenwert verschiedener Biologika in der Praxis. Deutsches Ärzteblatt Online.
Crossref